ABBOTT PARK, Ill. — Abbott today announced the launch of Libre Assist, a new feature built into the Libre app designed to help people living with diabetes make informed, real-time food choices before they eat.
Unlike traditional food-logging tools that give feedback after meals, Libre Assist uses generative AI to predict how specific foods may impact glucose levels and provides personalized meal advice at the moment of choice. The feature is being launched during CES 2026 and will be available at no extra cost within the Libre app.
Libre Assist introduces a color-coded rating system — green for minor, yellow for moderate, and orange for major — to show a meal’s potential glucose impact. Users can take a photo of their food or type a description, then the system identifies ingredients, estimates the glucose response, and offers practical adjustments, such as swapping ingredients or changing meal order to help lower the impact.
After eating, the feature works with Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) technology to show how the meal actually affected the person’s glucose levels. This closed feedback loop aims to help users better understand their individual responses to different foods over time.
“For people living with diabetes, food decisions are constant and highly individualized,” said Marc Taub, vice president of technical operations for Abbott’s diabetes care business. “Libre Assist delivers predictive, personalized guidance before a meal and then confirms the outcome with CGM data afterward, giving people confidence and clarity with every bite.”
Abbott stated that Libre Assist can be accessed via the Insights tab in the Libre app, without the need for separate sign-up, subscription fee, or additional prescription. The company highlighted that although the feature uses AI to offer guidance, it is not meant to replace medical advice or be used for treatment decisions.
Abbott plans to showcase Libre Assist at CES 2026 in Las Vegas, emphasizing the company’s broader effort to integrate AI and connected health technologies to assist people managing chronic conditions with everyday decisions.
